MARKET NEWS

 

EpicentRx BETA-PRIME Phase 1 Study Progresses After Demonstrating Good Safety & Tolerability
Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing Capabilities
Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate
Genovac Acquires the Carterra LSA Instrument to Enable State-of-the-Art Antibody Screening & Characterization Services
Processa Pharmaceuticals Doses First Patient in Amended Phase 1B Protocol for PCS6422 Combined With Capecitabine (Next-Generation Capecitabine)
KemPharm Doses First Subject in Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate

  FEATURED EDITORIAL

  COMPANY PROFILE

Eurofins BioPharma Product Testing offers complete CMC Testing Services for the Bio/Pharmaceutical industry, including all starting materials, process intermediates, drug substances, drug product, packaging, and manufacturing support through our broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry and Microbiology. With a global capacity of more than 2,000,000 square feet of facilities and 37 locations worldwide, our network of GMP laboratories and vast experience allow us to support projects of any size from conception to market. Our local presence with four key sites in the US, including Lancaster, PA; Portage, MI; Columbia, MO; and San Diego, CA, ensures personal service backed by a unique global breadth of harmonized capabilities that supports all functional areas of bio/pharmaceutical drug development. Click here for more.

Video Spotlight: Lonza (Small Molecules)

  EXCLUSIVE ONLINE CONTENT

Blacktrace Launches Particle Works – The New Dedicated Particle Engineering Brand

Blacktrace Launches Particle Works – The New Dedicated Particle Engineering Brand

Particle Works’ game-changing particle engineering platforms are set to revolutionize the way customers discover, develop and scale-up particle production for a wide range of….

Catalent to Invest 0 Million in Integrated Biologics Drug Substance & Drug Product Manufacturing 

Catalent to Invest $350 Million in Integrated Biologics Drug Substance & Drug Product Manufacturing 

Catalent recently announced a multi-year $350-million investment at its facility in Bloomington, IN, to expand biologics drug substance and drug product manufacturing….

Brooklyn ImmunoTherapeutics Announces Establishment of New R&D Facility for Advancement of Engineered Cellular Medicines

Brooklyn ImmunoTherapeutics Announces Establishment of New R&D Facility for Advancement of Engineered Cellular Medicines

Brooklyn ImmunoTherapeutics, Inc. recently announced the establishment of a new corporate and research and development facility at The Boardwalk at Science Center Drive in San Diego, CA, to support translational….

ProMed Pharma Announces Preclinical Rat Study to Assess Pharmacokinetics of Novel Long-Acting Contraceptive Implant

ProMed Pharma Announces Preclinical Rat Study to Assess Pharmacokinetics of Novel Long-Acting Contraceptive Implant

ProMed Pharma recently announce the initiation of preclinical evaluation of a novel fully resorbable contraceptive implant. The implant, developed in a project funded by the Bill & Melinda….

Cocrystal Pharma Collaborates With the NIAD to Evaluate COVID-19 Protease Inhibitors

Cocrystal Pharma Collaborates With the NIAD to Evaluate COVID-19 Protease Inhibitors

Cocrystal Pharma, Inc. recently announced a Non-Clinical Evaluation Agreement (NCEA) with the National Institute of Allergy and Infectious Diseases (NIAID) for exploratory preclinical studies to….

  WHITEPAPERS & WEBINARS

On-Demand Webinar: How to Safely Handle Your Antibody Drug Conjugate

On-Demand Webinar: How to Safely Handle Your Antibody Drug Conjugate

Antibody Drug Conjugates (ADCs) have a highly specific mechanism of action which is an advantage for the treatment of several oncology indications…..

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

WEBINAR: BPOG 2020 & USP 665 – Extractables Testing of Single-Use Systems

This webinar will explore how to conduct effective extractables and leachables (E&L) testing on plastic process materials used during pharmaceutical and biopharmaceutical manufacturing…..

  WHITEPAPERS & WEBINARS

WHITE PAPER - Making Sub-Visible Particles Visible: Innovative Analytical Techniques for Detection & Identification

WHITE PAPER - Making Sub-Visible Particles Visible: Innovative Analytical Techniques for Detection & Identification

The demand for complex, often life-saving drug substances such as monoclonal antibodies, interferons, and peptides is on the rise, creating a greater need for innovative delivery mechanisms to administer these new therapeutics. For a variety of reasons, sub-visible particles can …

WHITE PAPER - Poloxamer: A Simple & Powerful Solution for Accelerating Dissolution

WHITE PAPER - Poloxamer: A Simple & Powerful Solution for Accelerating Dissolution

Absorption of molecules from the gastrointestinal tract is an essential consideration when developing orally delivered medications. Solubility, the concentration of drug in solution, is essential for this to occur and it is important to also consider the dissolution rate of …

WHITE PAPER: Controlled Synthesis of Lipid Nanoparticles Using the Automated Nanoparticle System

WHITE PAPER: Controlled Synthesis of Lipid Nanoparticles Using the Automated Nanoparticle System

ABSTRACT

Lipid nanoparticles (LNPs) are powerful carriers for the delivery of biotherapeutics and active pharmaceutical ingredients (APIs). They are attractive due to their size and biocompatibility, which are important factors when determining the efficacy of an encapsulated API. Particle Works’ …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 4 – Transdermal/Topical Delivery
May 11 – Particle Design Technology